AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Siglyn M 100/500 Tablet ER

Prescription Icon
Prescription Required

Marketer

Zydus Healthcare Limited

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Siglyn M 100/500 Tablet ER

Duo-Med 100/500 Extended-Release tablets manage elevated blood glucose in type 2 diabetes patients by combining two active ingredients. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risks. Duo-Med 100/500 ER may be used independently or alongside other diabetic treatments, and achieves optimal results with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood glucose readings, and current medications. Consuming it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your physician's guidance. Adherence to your prescribed diet and exercise plan is crucial for diabetes management; lifestyle significantly impacts control. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headaches, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, particularly when used with insulin or sulfonylureas; learn its symptoms and management. This medication isn't suitable for all individuals. Inform your doctor of any history of liver, kidney, or heart disease, pancreatic issues, or significant alcohol consumption before starting. Pregnant or nursing individuals require physician consultation. Other medications may interact with Duo-Med 100/500 ER; disclose all medications for safety. Alcohol should be minimized due to its blood sugar-lowering effects. Your doctor will monitor your kidney function and blood sugar levels throughout treatment.

Uses of Siglyn M 100/500 Tablet ER

Managing Type 2 Diabetes

Major Benefits of Siglyn M 100/500 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Siglyn M 100/500 Tablet ER should be taken with a meal.

Common Side effects of Siglyn M 100/500 Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Siglyn M 100/500 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Siglyn M 100/500 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Siglyn M 100/500 Tablet ER works:

Siglyn M 100/500 Extended-Release tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action leads to more effective blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Siglyn M 100/500 Tablet ER and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Siglyn M 100/500 Extended-Release tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Siglyn M 100/500 tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Siglyn M 100/500 ER tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Avoid administering Siglyn M 100/500 ER tablets to patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Extended-release Siglyn M 100/500 tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is advised.

What if you forget to take Siglyn M 100/500 Tablet ER :

Should you forget to take a Siglyn M 100/500 Tablet ER, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Siglyn M 100/500 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Siglyn M 100/500 Tablet ER

Siglyn M 100/500 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Siglyn M 100/500 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia and neurological issues, including tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Siglyn M 100/500 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Siglyn M 100/500 Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Siglyn M 100/500 Tablet ER and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Siglyn M 100/500 Tablet ER) can rarely cause lactic acidosis, a serious condition with high blood lactic acid levels (also called MALA – Metformin-associated lactic acidosis). This is a medical emergency. To minimize risk, it's avoided in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Siglyn M 100/500 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Siglyn M 100/500 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Siglyn M 100/500 Tablet ER components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Siglyn M 100/500 Tablet ER with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Siglyn M 100/500 Tablet ER) can rarely cause lactic acidosis, a serious condition with dangerously high blood lactic acid levels (also called Metformin-associated lactic acidosis or MALA). This risk is higher in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Siglyn M 100/500 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Siglyn M 100/500 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Siglyn M 100/500 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Siglyn M 100/500 Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Siglyn M 100/500 Tablet ER is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Siglyn M 100/500 Tablet ER) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as Metformin-associated lactic acidosis or MALA). This risk is increased in patients with kidney disease, the elderly, and heavy alcohol users, so it's avoided in these groups. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Siglyn M 100/500 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication and ensure it's inaccessible to children, pets, and others.
Siglyn M 100/500 Tablet E...
190